Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-19 Purchase |
2022-12-21 4:52 pm |
Astria Therapeutics Inc. | ATXS | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director |
908,265 | $11.01 | $9,999,998 | 2,189,462 (Indirect) |
View |
| 2021-11-19 Purchase |
2021-11-23 4:12 pm |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
100 | $6.695 | $670 | 100 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2023-04-19 08:09 am |
N/A 2024-08-26 |
Astria Therapeutics Inc. | ATXS | Matthews Andrea Chief Business Officer |
0 | $0 | 171,431 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-02 08:51 am |
N/A 2032-07-31 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2022-06-21 08:33 am |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | KISHBAUCH MICHAEL D Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2022-06-21 08:33 am |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | BATE KENNETH Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2022-06-21 08:33 am |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Violin Jonathan Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2022-06-21 08:32 am |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Beck Joanne T. Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2022-06-21 08:32 am |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Cole Hugh M Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2022-06-21 08:32 am |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2022-06-21 08:31 am |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Callori Fred Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-09 6:01 pm |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | KISHBAUCH MICHAEL D Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-09 6:00 pm |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | BATE KENNETH Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-09 5:59 pm |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Violin Jonathan Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-09 5:58 pm |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Beck Joanne T. Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-09 5:57 pm |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Cole Hugh M Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-09 5:56 pm |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-09 5:54 pm |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Callori Fred Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:21 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Harshbarger Benjamin Chief Legal Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:20 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Clauser Noah Chief Financial Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:19 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Milne Jill C. CEO and President |
195,000 | $0 | 195,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:18 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Nichols Andrew John Chief Scientific Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:17 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-12-28 Ownership |
2022-02-10 4:08 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
45 | $0 | 100 (Direct) |
View |
Ownership |
2022-02-10 4:08 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
0 | $0 | 100 (Indirect) |
View |
| 2021-09-20 Other |
2021-09-22 5:00 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Violin Jonathan Director |
263,321 | $0 | 789,963 (Indirect) |
View |
| 2021-06-08 Option Award |
2021-06-10 4:06 pm |
N/A 2031-06-07 |
CATABASIS PHARMACEUTICALS INC | CATB | Harshbarger Benjamin Chief Legal Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:19 pm |
N/A 2031-03-31 |
CATABASIS PHARMACEUTICALS INC | CATB | Komjathy Andrew Chief Commercial Officer |
600,000 | $0 | 600,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:18 pm |
N/A 2031-03-31 |
CATABASIS PHARMACEUTICALS INC | CATB | Nichols Andrew John Chief Scientific Officer |
600,000 | $0 | 600,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:18 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | Callori Fred Director |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:17 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | Violin Jonathan Director |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:17 pm |
N/A 2031-03-31 |
CATABASIS PHARMACEUTICALS INC | CATB | Clauser Noah Chief Financial Officer |
600,000 | $0 | 600,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:16 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | KISHBAUCH MICHAEL D Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:16 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | BATE KENNETH Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:15 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | Beck Joanne T. Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:15 pm |
N/A 2031-03-31 |
CATABASIS PHARMACEUTICALS INC | CATB | Milne Jill C. CEO and President |
1,400,000 | $0 | 1,400,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:14 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | Cole Hugh M Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:13 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | LAPOINTE ANTHONY GREGG Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:13 pm |
N/A 2031-03-31 |
CATABASIS PHARMACEUTICALS INC | CATB | Harshbarger Benjamin Senior VP, General Counsel |
400,000 | $0 | 400,000 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 7:15 pm |
N/A N/A |
CATABASIS PHARMACEUTICALS INC | CATB | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Xontogeny LLC Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner |
6,468 | $3,010 | 35,771 (Indirect) |
View |